Get started
ARGENICA THERAPEUTICS LIMITEDARGENICA THERAPEUTICS LIMITEDARGENICA THERAPEUTICS LIMITED

ARGENICA THERAPEUTICS LIMITED

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

AGN chart


Full chart

AGN upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪92.23 M‬ AUD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.050 AUD
Net income (FY)
‪−5.48 M‬ AUD
Revenue (FY)
0.00 AUD
Shares float
‪114.98 M‬
Beta (1Y)
1.21

About ARGENICA THERAPEUTICS LIMITED


Sector
Health Technology
Industry
Biotechnology
CEO
Liz Dallimore
Website
argenica.com.au
Headquarters
Nedlands
Founded
2019
ISIN
AU0000150328
FIGI
BBG010YS0TD1
Argenica Therapeutics Ltd. provides neuroprotective treatment. It specializes in development and commercialization of a novel therapeutic known as ARG-007. It offers drug ARG-007 in multiple models of stroke and other central nervous system (CNS) injury models, specifically: stroke including non-human primates; traumatic brain injury; and perinatal hypoxia ischaemia. The company was founded on 20 November 2019 and is headquartered in Nedlands, Australia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

AGN news



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as AGN.

Frequently Asked Questions


The current price of AGN is 0.730 AUD — it hasn't changed in the past 24 hours. Watch ARGENICA THERAPEUTICS LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange ARGENICA THERAPEUTICS LIMITED stocks are traded under the ticker AGN.
AGN stock has fallen by −9.43% compared to the previous week, the month change is a 2.13% rise, over the last year ARGENICA THERAPEUTICS LIMITED has showed a 3.55% increase.
We've gathered analysts' opinions on ARGENICA THERAPEUTICS LIMITED future price: according to them, AGN price has a max estimate of 1.40 AUD and a min estimate of 1.40 AUD. Watch AGN chart and read a more detailed ARGENICA THERAPEUTICS LIMITED stock forecast: see what analysts think of ARGENICA THERAPEUTICS LIMITED and suggest that you do with its stocks.
AGN reached its all-time high on Jan 17, 2022 with the price of 1.020 AUD, and its all-time low was 0.180 AUD and was reached on Jun 22, 2021. View more price dynamics on AGN chart.
See other stocks reaching their highest and lowest prices.
AGN stock is 2.74% volatile and has beta coefficient of 1.21. Track ARGENICA THERAPEUTICS LIMITED stock price on the chart and check out the list of the most volatile stocks — is ARGENICA THERAPEUTICS LIMITED there?
Yes, you can track ARGENICA THERAPEUTICS LIMITED financials in yearly and quarterly reports right on TradingView.
ARGENICA THERAPEUTICS LIMITED is going to release the next earnings report on Aug 20, 2025. Keep track of upcoming events with our Earnings Calendar.
AGN net income for the last half-year is ‪−1.19 M‬ AUD, while the previous report showed ‪−4.07 M‬ AUD of net income which accounts for 70.83% change. Track more ARGENICA THERAPEUTICS LIMITED financial stats to get the full picture.
No, AGN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, AGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ARGENICA THERAPEUTICS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ARGENICA THERAPEUTICS LIMITED technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ARGENICA THERAPEUTICS LIMITED stock shows the buy signal. See more of ARGENICA THERAPEUTICS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.